Suprefact is a synthetic hormone medication primarily used in the management of prostate cancer and to treat endometriosis, a condition characterized by the abnormal growth of endometrial tissue outside the uterus. It works by suppressing the production of certain hormones in the body, such as testosterone in men and estrogen in women, which can help reduce the growth of hormone-sensitive tissues and tumors. Suprefact is also utilized in controlled ovarian stimulation protocols during assisted reproductive technologies (ART) like in vitro fertilization (IVF) to prevent premature ovulation. The medication can be administered through nasal spray or injection, depending on the condition being treated and the patient's specific needs. As with any medication, it is important to use Suprefact under the guidance of a healthcare professional to ensure its efficacy and manage any potential side effects.